Literature DB >> 26955594

SkIndia Quiz 22: Scalp Tumor.

Leonor Neto Lopes1, Luís Soares-Almeida1, Paulo Filipe1.   

Abstract

Entities:  

Year:  2016        PMID: 26955594      PMCID: PMC4763591          DOI: 10.4103/2229-5178.169808

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


× No keyword cloud information.
A 72-year-old Caucasian male presented with a four month history of an asymptomatic, violaceous, ulcerated tumor over the scalp of 3 cm diameter surrounded by multifocal violaceous nodules [Figure 1]. He reported local trauma 1 month prior to appearance of the lesion. There was no lymphadenopathy or hepatosplenomegaly. Histopathologic examination showed a vascular tumoral lesion occupying the entire dermis, with a jagged irregular branching angiomatous pattern with vascular clefts between the collagen fibers filled with erythrocytes and lymphocytes around vessels [Figure 2a]. The endothelial cells were polygonal with hyperchromatic nuclei and rare atypical mitoses. The immunostaining was positive for CD31, CD34 and FVIII-related antigen [Figure 2b].
Figure 1

Violaceous ulcerated tumor on the scalp surrounded by multifocal violaceous nodules

Figure 2

(a) Histopathologic examination showed a vascular tumoral lesion on the dermis, with irregular vascular clefts between the collagen fibers filled with erythrocytes and lymphocytes (H and E ×100), (b) Immunostaining positive for FVIII-related antigen

Violaceous ulcerated tumor on the scalp surrounded by multifocal violaceous nodules (a) Histopathologic examination showed a vascular tumoral lesion on the dermis, with irregular vascular clefts between the collagen fibers filled with erythrocytes and lymphocytes (H and E ×100), (b) Immunostaining positive for FVIII-related antigen

ANSWER

Diagnosis - Idiopathic cutaneous angiosarcoma of the scalp. Cutaneous angiosarcoma is a rare, malignant tumor of vascular endothelial cells.[12] It usually affects the face and scalp region, most often in elderly patients.[12] Men are more frequently affected than women in a ratio of 3:1.[2] The clinical presentation of angiosarcoma is quite variable.[2] It has three clinical settings: Angiosarcoma in the elderly, post.-radiation, or associated with chronic lymphedema.[34] Angiosarcoma accounts for approximately 10% of soft.-tissue sarcomas of the head and neck.[25] It is histopathologically characterized by irregular vascular channels dissecting between collagen bundles lined by hyperchromatic atypical endothelium and chronic inflammation.[3] Vascular and lymphatic immunohistochemical markers are essential to establish the diagnosis… - CD31, CD34, factor.-VIII and podoplanin are positive.[356] One of the main differential diagnoses is Kaposi sarcoma, in which spindled cells are CD34 and variably CD31. positive, but anti-human herpes-virus-8 antibody is always positive.[3] Angiosarcoma treatment includes surgery, wide.-field post.-operative radiotherapy and/or palliative chemotherapy.[5] The local-regional recurrence is high and the prognosis very poor. (5-year survival rate of approximately 10%).[2] This tumor can metastasize by lymphatic or hematogenous routes to the lung, lymph nodes and bone.[25] The most important determinant factors of outcome are tumor diameter, depth of invasion, margin status, recurrence and metastasis.[57]
  6 in total

1.  MALIGNANT ANGIOENDOTHELIOMA OF THE SKIN.

Authors:  E W JONES
Journal:  Br J Dermatol       Date:  1964-01       Impact factor: 9.302

2.  Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica.

Authors:  F W STEWART; N TREVES
Journal:  Cancer       Date:  1948-05       Impact factor: 6.860

3.  Association of D2-40 and MMP-1 expression with cyst formation in lung metastatic lesions of cutaneous angiosarcoma on the scalp: immunohistochemical analysis of 23 autopsy cases.

Authors:  Mamiko Masuzawa; Tetuo Mikami; Yoshiko Numata; Wataru Tokuyama; Mikio Masuzawa; Yoshiki Murakumo; Isao Okayasu; Kensei Katsuoka
Journal:  Hum Pathol       Date:  2013-10-11       Impact factor: 3.466

4.  Angiosarcomas of the head and neck: a clinico-immunohistochemical study of 8 consecutive patients.

Authors:  X J Yang; J W Zheng; Q Zhou; W M Ye; Y A Wang; H G Zhu; L Z Wang; Z Y Zhang
Journal:  Int J Oral Maxillofac Surg       Date:  2010-04-21       Impact factor: 2.789

5.  Cutaneous angiosarcoma: a case series with prognostic correlation.

Authors:  Michael B Morgan; Michael Swann; Stephen Somach; William Eng; Bruce Smoller
Journal:  J Am Acad Dermatol       Date:  2004-06       Impact factor: 11.527

6.  Cutaneous angiosarcoma of the scalp: a multidisciplinary approach.

Authors:  Timothy M Pawlik; Augusto F Paulino; Cornelius J McGinn; Laurence H Baker; Deborah S Cohen; Jeffery S Morris; Riley Rees; Vernon K Sondak
Journal:  Cancer       Date:  2003-10-15       Impact factor: 6.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.